Clotrimazole disrupts glycolysis in human breast cancer without affecting non-tumoral tissues

Molecular Genetics and Metabolism

Volumn 103, Issue 4, 2011, Pages 394-398

  Coelho, Raquel Guimarães ^a   Calaça, Isadora de Castro ^a   Celestrini, Deborah de Moura ^a   Correia, Ana Helena ^a   Costa, Mauricio Augusto Silva Magalhães ^a   Sola Penna, Mauro ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Breast cancer; Glycolysis; Metabolism; Treatment; Warburg effect

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CLOTRIMAZOLE; F ACTIN; GLUCOSE; GLYCOLYTIC ENZYME; LACTIC ACID;

ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; FRACTIONATION; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ACTINS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CLOTRIMAZOLE; FEMALE; GLUCOSE; GLYCOLYSIS; HUMANS; LACTIC ACID; PHOSPHOFRUCTOKINASE-1;

EID: 79960840829     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.04.003     Document Type: Article

References (42)

1. Glass-Marmor L., Beitner R. Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists. Eur. J. Pharmacol. 1997, 328:241-248.
2. Glass-Marmor L., Morgenstern H., Beitner R. Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells. Eur. J. Pharmacol. 1996, 313:265-271.
3. Marcondes M.C., Sola-Penna M., Zancan P. Clotrimazole potentiates the inhibitory effects of ATP on the key glycolytic enzyme 6-phosphofructo-1-kinase. Arch. Biochem. Biophys. 2010, 497:62-67.
4. Meira D.D., Marinho-Carvalho M.M., Teixeira C.A., Veiga V.F., Da Poian A.T., Holandino C., de Freitas M.S., Sola-Penna M. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Mol. Genet. Metab. 2005, 84:354-362.
5. Penso J., Beitner R. Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology. Mol. Genet. Metab. 2002, 76:181-188.
6. Penso J., Beitner R. Clotrimazole decreases glycolysis and the viability of lung carcinoma and colon adenocarcinoma cells. Eur. J. Pharmacol. 2002, 451:227-235.
7. Rodrìguez-Enrìquez S., Marìn-Hernndez A., Gallardo-PÈrez J.C., Carreòo-Fuentes L., Moreno-Snchez R. Targeting of cancer energy metabolism. Mol. Nutr. Food Res. 2009, 53:29-48.
8. Zancan P., Rosas A.O., Marcondes M.C., Marinho-Carvalho M.M., Sola-Penna M. Clotrimazole inhibits and modulates heterologous association of the key glycolytic enzyme 6-phosphofructo-1-kinase. Biochem. Pharmacol. 2007, 73:1520-1527.
9. Ashrafian H. Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis. Lancet 2006, 367:618-621.
10. Beckner M.E., Stracke M.L., Liotta L.A., Schiffmann E. Glycolysis as primary energy source in tumor cell chemotaxis. J. Natl. Cancer. Inst. 1990, 82:1836-1840.
11. Chen E.I., Hewel J., Krueger J.S., Tiraby C., Weber M.R., Kralli A., Becker K., Yates J.R., Felding-Habermann B. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res. 2007, 67:1472-1486.
12. Costello L.C., Franklin R.B. 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis. Mol. Cell. Biochem. 2005, 280:1-8.
13. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
14. A. Marin-Hernandez, J.C. Gallardo-Perez, S. Rodriguez-Enrìquez, R. Encalada, R. Moreno-Sanchez, E. Saavedra, Modeling cancer glycolysis, Biochimica et Biophysica Acta (BBA)-Bioenergetics (2011). http://DOI:10.1016/j.bbabio.2010.11.006.
15. Pelicano H., Martin D.S., Xu R.H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
16. Moreno-Sanchez R., Rodriguez-Enriquez S., Saavedra E., Marin-Hernandez A., Gallardo-Perez J.C. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells?. Biofactors 2009, 35:209-225.
17. Semenza G.L. Tumor metabolism: cancer cells give and take lactate. J. Clin. Invest. 2008, 118:3835-3837.
18. Sola-Penna M. Metabolic regulation by lactate. IUBMB Life 2008, 60:605-608.
19. Sola-Penna M., Da Silva D., Coelho W.S., Marinho-Carvalho M.M., Zancan P. Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism. IUBMB Life 2010, 62:791-796.
20. Zancan P., Sola-Penna M., Furtado C.M., Da Silva D. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol. Genet. Metab. 2010, 100:372-378.
21. El-Bacha T., de Freitas M.S., Sola-Penna M. Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Mol. Genet. Metab. 2003, 79:294-299.
22. Maia J.C.C., Gomes S.L., Juliani M.H., Morel C.M. Preparation of [†-32 P] and [a-32 P]-nucleoside triphosphate, with high specific activity. Genes and Antigenes of Parasites: A Laboratory Manual 1983, 146-157. FIOCRUZ, Rio de Janeiro, Brazil.
23. Real-Hohn A., Zancan P., Da Silva D., Martins E.R., Salgado L.T., Mermelstein C.S., Gomes A.M., Sola-Penna M. Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 2010, 92:538-544.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
25. Sola-Penna M., dos Santos A.C., Alves G.G., El-Bacha T., Faber-Barata J., Pereira M.F., Serejo F.C., Da Poian A.T., Sorenson M. A radioassay for phosphofructokinase-1 activity in cell extracts and purified enzyme. J. Biochem. Biophys. Methods 2002, 50:129-140.
26. Zancan P., Sola-Penna M. Calcium influx: a possible role for insulin modulation of intracellular distribution and activity of 6-phosphofructo-1-kinase in human erythrocytes. Mol. Genet. Metab. 2005, 86:392-400.
27. Zancan P., Sola-Penna M. Regulation of human erythrocyte metabolism by insulin: cellular distribution of 6-phosphofructo-1-kinase and its implication for red blood cell function. Mol. Genet. Metab. 2005, 86:401-411.
28. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
29. Chesney J. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:535-539.
30. Diaz-Ruiz R., Uribe-Carvajal S., Devin A., Rigoulet M. Tumor cell energy metabolism and its common features with yeast metabolism. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2009, 1796:252-265.
31. Levine A.J., Puzio-Kuter A.M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010, 330:1340-1344.
32. Marin-Hernandez A., Gallardo-Perez J.C., Ralph S.J., Rodriguez-Enriquez S., Moreno-Sanchez R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev. Med. Chem. 2009, 9:1084-1101.
33. Spitz G.A., Furtado C.M., Sola-Penna M., Zancan P. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem. Pharmacol. 2009, 77:46-53.
34. Glass-Marmor L., Beitner R. Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases the levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP. Eur. J. Pharmacol. 1999, 370:195-199.
35. Schwartz D., Beitner R. Detachment of the glycolytic enzymes, phosphofructokinase and aldolase, from cytoskeleton of melanoma cells, induced by local anesthetics. Mol. Genet. Metab. 2000, 69:159-164.
36. Leite T.C., Coelho R.G., Silva D.D., Coelho W.S., Marinho-Carvalho M.M., Sola-Penna M. Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice. FEBS Lett. 2011, 585:92-98.
37. Leite T.C., Da Silva D., Coelho R.G., Zancan P., Sola-Penna M. Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis. Biochem. J. 2007, 408:123-130.
38. Karniel M., Beitner R. Local anesthetics induce a decrease in the levels of glucose 1, 6-bisphosphate, fructose 1,6-bisphosphate, and ATP, and in the viability of melanoma cells. Mol. Genet. Metab. 2000, 69:40-45.
39. Alves G.G., Sola-Penna M. Epinephrine modulates cellular distribution of muscle phosphofructokinase. Mol. Genet. Metab. 2003, 78:302-306.
40. Coelho W.S., Costa K.C., Sola-Penna M. Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. Mol. Genet. Metab. 2007, 92:364-370.
41. Da Silva D., Zancan P., Coelho W.S., Gomez L.S., Sola-Penna M. Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. Arch. Biochem. Biophys. 2010, 496:53-60.
42. Silva A.P., Alves G.G., Araujo A.H., Sola-Penna M. Effects of insulin and actin on phosphofructokinase activity and cellular distribution in skeletal muscle. An. Acad. Bras. Cienc. 2004, 76:541-548.